These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori. Xing Y; Liu W; Li X; Guo L; Lv X; Xi T Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472 [TBL] [Abstract][Full Text] [Related]
9. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant]. Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324 [TBL] [Abstract][Full Text] [Related]
10. Progress in vaccination against Helicobacter pylori. Sutton P Vaccine; 2001 Mar; 19(17-19):2286-90. PubMed ID: 11257349 [TBL] [Abstract][Full Text] [Related]
11. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734 [TBL] [Abstract][Full Text] [Related]
12. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447 [TBL] [Abstract][Full Text] [Related]
13. Orogastric vaccination of guinea pigs with Helicobacter pylori sonicate and a high dose of cholera toxin lowers the burden of infection. Durrani Z; Rijpkema S FEMS Immunol Med Microbiol; 2003 May; 36(3):169-73. PubMed ID: 12738387 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017 [TBL] [Abstract][Full Text] [Related]
15. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469 [TBL] [Abstract][Full Text] [Related]
16. Vaccine-induced gastric CD4 Xu N; Ruan G; Liu W; Hu C; Huang A; Zeng Z; Luo S; Zhang Z; Fan M; Ye F; Xi T; Xing Y Helicobacter; 2019 Oct; 24(5):e12652. PubMed ID: 31414552 [TBL] [Abstract][Full Text] [Related]
17. Host response and vaccine development to Helicobacter pylori infection. Blanchard TG; Czinn SJ; Nedrud JG Curr Top Microbiol Immunol; 1999; 241():181-213. PubMed ID: 10087662 [TBL] [Abstract][Full Text] [Related]
18. Vaccine against Helicobacter pylori: fact or fiction? Michetti P Gut; 1997 Dec; 41(6):728-30. PubMed ID: 9462202 [No Abstract] [Full Text] [Related]
19. Helicobacter pylori vaccine development: facing the challenge. Aebischer T; Schmitt A; Walduck AK; Meyer TF Int J Med Microbiol; 2005 Sep; 295(5):343-53. PubMed ID: 16173501 [TBL] [Abstract][Full Text] [Related]
20. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Li X; Xing Y; Guo L; Lv X; Song H; Xi T Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]